The Enterprise Value as of February 2026 (TTM) for Atossa Therapeutics, Inc. (ATOS) is -5860129.00

According to Atossa Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -5860129.00. This represents a change of -100.38% compared to the average of 1.53B of the last 4 quarters.

Atossa Therapeutics, Inc. (ATOS) Historical Enterprise Value (quarterly & annually)

How has ATOS Enterprise Value performed in the past?

The mean historical Enterprise Value of Atossa Therapeutics, Inc. over the last ten years is 744.57M. The current -5860129.00 Enterprise Value has changed -178.70% with respect to the historical average. Over the past ten years (40 quarters), ATOS's Enterprise Value was at its highest in in the June 2021 quarter at 11.38B. The Enterprise Value was at its lowest in in the March 2018 quarter at 13.12M.

Atossa Therapeutics, Inc. (ATOS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Atossa Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Atossa Therapeutics, Inc. (ATOS) Average Enterprise Value

How has ATOS Enterprise Value performed in the past?

The current Enterprise Value of Atossa Therapeutics, Inc. (ATOS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Atossa Therapeutics, Inc. (ATOS) Enterprise Value vs. Peers

How is ATOS’s Enterprise Value compared to its peers?

Atossa Therapeutics, Inc.’s Enterprise Value is less than Oncolytics Biotech Inc. (109.91M), less than Tevogen Bio Holdings Inc. (61.83M), less than Greenwich LifeSciences, Inc. (397.97M), less than Instil Bio, Inc. (131.75M), less than Immix Biopharma, Inc. (211.44M), less than Whitehawk Therapeutics Inc (92.14M), less than Clene Inc. (53.30M), less than Surrozen, Inc. (121.18M), less than Cognition Therapeutics, Inc. (38.55M), less than Coya Therapeutics, Inc. (52.29M),

Build a custom stock screener for Atossa Therapeutics, Inc. (ATOS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atossa Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atossa Therapeutics, Inc. (ATOS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atossa Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.